Anisotropine methylbromide and Prolymphocytic leukaemia - from FDA reports
There is no Prolymphocytic leukaemia reported by people who take Anisotropine methylbromide yet. This review analyzes which people have Prolymphocytic leukaemia with Anisotropine methylbromide. It is created by eHealthMe based on reports from FDA, and is updated regularly.
What to expect?
You are not alone!
Personalized health information
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>
On Jan, 19, 2018
No report is found.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Subscribe to the study: get notified of updates to the study.
Do you have Prolymphocytic leukaemia when taking Anisotropine methylbromide?
- Check symptoms - is prolymphocytic leukaemia caused by a drug or a condition?
- Get alerts to symptoms - forecast your symptoms and get alerts
- Report the side effect - help people in need and in real time
- Ask a question - ask a question related to the study
- write a post - share your experience related to the study
- More tools...
Expand the study to include all drugs with the same ingredientsProlymphocytic leukaemia and drugs with ingredients of anisotropine methylbromide.
Expand the study to include reports from both FDA and eHealthMeProlymphocytic leukaemia and Anisotropine methylbromide from FDA and eHealthMe reports
Anisotropine methylbromide has active ingredients of anisotropine methylbromide. (latest outcomes from Anisotropine methylbromide 1 users)
Prolymphocytic leukaemia (cancer of the blood or bone marrow characterized by an abnormal increase of immature white blood cells) has been reported by people with non-hodgkin's lymphoma, cytomegalovirus infection, prolymphocytic leukaemia, urinary tract infection, sepsis (latest reports from 85 Prolymphocytic leukaemia patients).